BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Transition Therapeutics Inc. 

415 Yonge Street
Suite 1103
Toronto  Ontario  M5B2E7  Canada
Phone: 416-260-7770 Fax: 416-260-2886


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Transition Therapeutics Inc. (TTH.TO) Announces Fiscal 2014 Year End Financial Results 9/26/2014 8:29:10 AM
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Full Year Fiscal 2014 Financial Results On Thursday, September 25th, At 4:30 P.M. EST 9/22/2014 8:28:39 AM
Transition Therapeutics Inc. (TTH.TO) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 9/5/2014 12:54:16 PM
Transition Therapeutics Inc. (TTH.TO) Appoints Carl Damiani As Chief Operating Officer 7/11/2014 9:10:43 AM
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Private Placement Equity Financing 6/23/2014 6:34:20 AM
Transition Therapeutics Inc. (TTH.TO) Enters Into Deal With Investors To Receive Up To $30.8 Million 6/6/2014 7:09:14 AM
Transition Therapeutics Inc. (TTH.TO) To Host Investor Day And Webcast On May 28th In New York City 5/27/2014 6:35:20 AM
Transition Therapeutics Inc. (TTH.TO) Diabetes Drug Candidate, TT-401, Commences Phase 2 Clinical Study 5/15/2014 12:25:42 PM
Transition Therapeutics Inc. (TTH.TO) Announces Third Quarter Fiscal 2014 Financial Results 5/14/2014 6:22:08 AM
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Third Quarter Fiscal 2014 Financial Results On Tuesday, May 13th, At 4:30 P.M. EST 5/12/2014 6:39:00 AM
12345678910...